High-sensitivity C-reactive protein (hs-CRP) was recently identified as an independent predictor of atherosclerotic vascular disease. The physiological significance of elevated hs-CRP remains to be evaluated, however. To determine the relationship between hs-CRP and insulin resistance and serum E-selectin, an endothelial activation marker, we conducted a case-control study of 45 diabetic patients with high hs-CRP (≥ 0.10 mg/d
l) and 45 age-and gender-matched diabetic patients with low hs-CRP (≤0.03 mg/d
l). Patients with high hs-CRP had a significantly greater body mass index and triglycerides, and significantly lower HDL cholesterol. Insulin sensitivity, measured by the K index of the insulin tolerance test (Kitt), was significantly lower in patients with high hs-CRP than in those with low hs-CRP (2.29 ± 0.88 vs. 2.82 ± 1.11%/min, mean ± SD, p<0.05). The mean soluble adhesion molecule, E-selectin, was significantly higher in patients with high hs-CRP than in those with low hs-CRP (70.9 ± 29.8 vs. 55.4 ± 30.8 ng/ml, p<0.01). Our results indicate that elevated hs-CRP in patients with type 2 diabetes reflect the presence of insulin resis tance and endothelial activation.
View full abstract